Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

NCT04433234 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: DS-5141b

Sponsor

Daiichi Sankyo Co., Ltd.